Abstract:Inducible nitric-oxide synthase (iNOS), a major mediator of inflammation, plays an important role in obesity-induced insulin resistance. Inhibition of iNOS by gene disruption or pharmacological inhibitors reverses or ameliorates obesity-induced insulin resistance in skeletal muscle and liver in mice. It is unknown, however, whether increased expression of iNOS is sufficient to cause insulin resistance in vivo. To address this issue, we generated liver-specific iNOS transgenic (L-iNOS-Tg) mice, where expression of the transgene, iNOS, is regulated under mouse albumin promoter. L-iNOS-Tg mice exhibited mild hyperglycemia, hyperinsulinemia, insulin resistance, and impaired insulin-induced suppression of hepatic glucose output, as compared with wild type (WT) littermates. Insulin-stimulated phosphorylation of insulin receptor substrate-1 (IRS-1) and -2, and Akt was significantly attenuated in liver, but not in skeletal muscle, of L-iNOS-Tg mice relative to WT mice without changes in insulin receptor phosphorylation. Moreover, liver-specific iNOS expression abrogated insulin-stimulated phosphorylation of glycogen synthase kinase-3β, forkhead box O1, and mTOR (mammalian target of rapamycin), endogenous substrates of Akt, along with increased S-nitrosylation of Akt relative to WT mice. However, the expression of insulin receptor, IRS-1, IRS-2, Akt, glycogen synthase kinase-3β, forkhead box O1, protein-tyrosine phosphatase-1B, PTEN (phosphatase and tensin homolog), and p85 phosphatidylinositol 3-kinase was not altered by iNOS transgene. Hyperglycemia was associated with elevated glycogen phosphorylase activity and decreased glycogen synthase activity in the liver of L-iNOS-Tg mice, whereas phosphoenolpyruvate carboxykinase, glucose-6-phosphatase, and proliferator-activated receptor γ coactivator-1α expression were not altered. These results clearly indicate that selective expression of iNOS in liver causes hepatic insulin resistance along with deranged insulin signaling, leading to hyperglycemia and hyperinsulinemia. Our data highlight a critical role for iNOS in the development of hepatic insulin resistance and hyperglycemia.

Inactivation of NF-κB p50 Leads to Insulin Sensitization in Liver through Post-translational Inhibition of p70S6K

Inactivation Of Nf-Kappa B P65 (Rela) In Liver Improves Insulin Sensitivity And Inhibits Camp/Pka Pathway

Uncoupling of Inflammation and Insulin Resistance by NF-κB in Transgenic Mice through Elevated Energy Expenditure

Uncoupling of Inflammation and Insulin Resistance by NF-κB in Transgenic Mice Through Elevated Energy Expenditure.

Altered Nuclear Factor-Kappab Inducing Kinase Expression in Insulin-Resistant Mice.

FKBP12.6-knockout mice display hyperinsulinemia and resistance to high-fat diet-induced hyperglycemia.

S6K Directly Phosphorylates IRS-1 on Ser-270 to Promote Insulin Resistance in Response to TNF-α Signaling through IKK2

Sustained NFκB Inhibition Improves Insulin Sensitivity but is Detrimental to Muscle Health

Inactivation of NF-κB2 (p52) Restrains Hepatic Glucagon Response Via Preserving PDE4B Induction

Nuclear Factor Κb–inducing Kinase Activation As a Mechanism of Pancreatic Β Cell Failure in Obesity

Liver NF-κB-Inducing Kinase Promotes Liver Steatosis and Glucose Counterregulation in Male Mice with Obesity

Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity

Activation of NF-κB-Inducing Kinase in Islet β Cells Causes β Cell Failure and Diabetes

NF-κB-inducing kinase (NIK) is activated in pancreatic β-cells but does not contribute to the development of diabetes

Inactivation of PKCθ leads to increased susceptibility to obesity and dietary insulin resistance in mice

P65 Inactivation in Adipocytes and Macrophages Attenuates Adipose Inflammatory Response in Lean but Not in Obese Mice.

Liver-specific Inducible Nitric-Oxide Synthase Expression is Sufficient to Cause Hepatic Insulin Resistance and Mild Hyperglycemia in Mice.

Blocking Nuclear Factor-Kappa B Protects Against Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice

Inactivation of PKCtheta leads to increased susceptibility to obesity and dietary insulin resistance in mice.

Islet α-cell Inflammation Induced By NF-κB inducing kinase (NIK) Leads to Hypoglycemia, Pancreatitis, Growth Retardation, and Postnatal Death in Mice

NF-κB–inducing Kinase (NIK) Promotes Hyperglycemia and Glucose Intolerance in Obesity by Augmenting Glucagon Action